Ai-Li Xu
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cardiovascular Disease and Adiposity 1
-
- 14-3-3 protein interactions 1
- Co-authors
- Jun Gao (2 shared papers)Zhen Shi (5 shared papers)Weifeng Li (2 shared papers)Qi Cui (1 shared paper)Jimin Gao (1 shared paper)Fei Li (1 shared paper)Zhen Zhang (1 shared paper)Weihua Bian (2 shared papers)
In The Last Decade
Ai-Li Xu
12 papers receiving 371 citations
Peers
Comparison fields: 5 of 69
- Geriatrics and Gerontology 55
- Cancer Research 107
- Biological Psychiatry 12
- Neurology 38
- Developmental Neuroscience 16
Countries citing papers authored by Ai-Li Xu
This map shows the geographic impact of Ai-Li Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai-Li Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai-Li Xu more than expected).
Fields of papers citing papers by Ai-Li Xu
This network shows the impact of papers produced by Ai-Li Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai-Li Xu. The network helps show where Ai-Li Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ai-Li Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 149 | |
| 2 | 2020 | 140 | |
| 3 | 2014 | 23 | |
| 4 | 2014 | 18 | |
| 5 | 2023 | 10 | |
| 6 | 2019 | 8 | |
| 7 | 2017 | 7 | |
| 8 | 2020 | 6 | |
| 9 | [Nasal carriage of community-acquired Staphylococcus aureus and drug sensitivity tests in healthy children in Chengdu]. | 2012 | 5 |
| 10 | 2025 | 3 | |
| 11 | Icariin protects against MPP+-induced neurotoxicity in MES23.5 cells. | 2016 | 3 |
| 12 | [Expression of Sema3A and NP-1 in spinal cord and spared dorsal root ganglion after partial dorsal root rhizotomy of cat]. | 2008 | 2 |
About Ai-Li Xu
Ai-Li Xu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Endocrine and Autonomic Systems, Immunology and Cancer Research, having authored 12 papers that have together received 374 indexed citations. Recurring topics across this work include Neuroscience of respiration and sleep (2 papers), Cancer Mechanisms and Therapy (1 paper), Genetics and Neurodevelopmental Disorders (1 paper), Sirtuins and Resveratrol in Medicine (1 paper), Cardiovascular Disease and Adiposity (1 paper), Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper), Biochemical effects in animals (1 paper) and 14-3-3 protein interactions (1 paper). The work is most often cited by research in Geriatrics and Gerontology (55 citations), Cancer Research (107 citations), Biological Psychiatry (12 citations), Neurology (38 citations) and Developmental Neuroscience (16 citations). Ai-Li Xu has collaborated with scholars based in China and Macao. Frequent co-authors include Jun Gao, Zhen Shi, Weifeng Li, Qi Cui, Jimin Gao, Fei Li, Zhen Zhang, Weihua Bian, Yeying Sun and Na Wang. Their work appears in journals such as Pflügers Archiv - European Journal of Physiology, Biochemical and Biophysical Research Communications, Molecular Neurobiology, Heliyon and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.